1707 related articles for article (PubMed ID: 8490470)
1. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
Lidegaard O
BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
[TBL] [Abstract][Full Text] [Related]
2. [Oral contraceptives and cerebral thromboembolism. A Danish case-control study].
Lidegaard O
Ugeskr Laeger; 1993 Nov; 155(44):3538-45. PubMed ID: 8236574
[TBL] [Abstract][Full Text] [Related]
3. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
4. Smoking and use of oral contraceptives: impact on thrombotic diseases.
Lidegaard O
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease.
Lidegaard O
Br J Obstet Gynaecol; 1995 Feb; 102(2):153-9. PubMed ID: 7756208
[TBL] [Abstract][Full Text] [Related]
6. The case for a lower dose pill. Assessing the impact of estrogen dose.
Brown S; Cropfield O
ORGYN; 1995; (2):36-9. PubMed ID: 12319251
[TBL] [Abstract][Full Text] [Related]
7. [Use of oral contraceptives in Denmark 1980-1990 and smoking habits among fertile women in 1990].
Lidegaard O
Ugeskr Laeger; 1993 Nov; 155(44):3550-8. PubMed ID: 8236576
[TBL] [Abstract][Full Text] [Related]
8. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
Lewis MA; Heinemann LA; Spitzer WO; MacRae KD; Bruppacher R
Contraception; 1997 Sep; 56(3):129-40. PubMed ID: 9347202
[TBL] [Abstract][Full Text] [Related]
9. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women.
Heinemann LA; Lewis MA; Thorogood M; Spitzer WO; Guggenmoos-Holzmann I; Bruppacher R
BMJ; 1997 Dec; 315(7121):1502-4. PubMed ID: 9420491
[TBL] [Abstract][Full Text] [Related]
10. The risks of venous thromboembolic disease among German women using oral contraceptives: a database study.
Farmer RD; Todd JC; Lewis MA; MacRae KD; Williams TJ
Contraception; 1998 Feb; 57(2):67-70. PubMed ID: 9589831
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
Carr BR; Ory H
Contraception; 1997 May; 55(5):267-72. PubMed ID: 9220222
[TBL] [Abstract][Full Text] [Related]
12. Progestogens in cardiovascular diseases: an introduction to the epidemiologic data.
Mann JI
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):752-7. PubMed ID: 7065056
[TBL] [Abstract][Full Text] [Related]
13. First-time use of newer oral contraceptives and the risk of venous thromboembolism.
Suissa S; Blais L; Spitzer WO; Cusson J; Lewis M; Heinemann L
Contraception; 1997 Sep; 56(3):141-6. PubMed ID: 9347203
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for fatal venous thromboembolism in young women: a case-control study.
Thorogood M; Mann J; Murphy M; Vessey M
Int J Epidemiol; 1992 Feb; 21(1):48-52. PubMed ID: 1544757
[TBL] [Abstract][Full Text] [Related]
15. On the epidemiology of oral contraceptives and disease.
Prentice RL; Thomas DB
Adv Cancer Res; 1987; 49():285-401. PubMed ID: 3314396
[TBL] [Abstract][Full Text] [Related]
16. Decline in cerebral thromboembolism among young women after introduction of low-dose oral contraceptives: an incidence study for the period 1980-1993.
Lidegaard O
Contraception; 1995 Aug; 52(2):85-92. PubMed ID: 8536452
[TBL] [Abstract][Full Text] [Related]
17. Effect of oral contraceptive progestins on serum copper concentration.
Berg G; Kohlmeier L; Brenner H
Eur J Clin Nutr; 1998 Oct; 52(10):711-5. PubMed ID: 9805216
[TBL] [Abstract][Full Text] [Related]
18. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
[TBL] [Abstract][Full Text] [Related]
19. Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany.
Farmer RD; Lawrenson RA
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S78-86. PubMed ID: 9753314
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptives and venous thromboembolism: a case-control study designed to minimize detection bias.
Realini JP; Encarnacion CE; Chintapalli KN; Rees CR
J Am Board Fam Pract; 1997; 10(5):315-21. PubMed ID: 9297655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
